Expression of mRNAs missing in metastasis in primary breast carcinoma and its clinical significance
Zheng Xiong-wei
Abstract
Zheng Xiong-wei
Abstract
Objective: To detect the expression of missing in metastasis(MIM) in human primary breast carcinoma and to evaluate its correlation with clinicopathological features.Methods: The expression of MIM mRNA was detected by SYBR Green quantitative real-time PCR in 60 samples of primary breast carcinoma and adjacent normal tissues,and its expression level was interpreted in terms of various clinical characteristics.Results: The expression of MIM mRNA in breast carcinoma was higher than that of adjacent tissues(P0.05) and it was associated with lymph node metastasis(P0.01),tumor size,and TNM stages(P0.05),but not age,histological grade,pathological type,ER,PR,CerbB-2 and Ki-67(P0.05).Conclusion: Overexpression of MIM mRNA may be a useful marker to predict metastasis of breast carcinoma.It may served as a biomarker for the prediction of moderate or advanced breast carcinoma,and may also prove to be a potential therapeutic target in breast carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To detect the expression of missing in metastasis(MIM) in human primary breast carcinoma and to evaluate its correlation with clinicopathological features.Methods: The expression of MIM mRNA was detected by SYBR Green quantitative real-time PCR in 60 samples of primary breast carcinoma and adjacent normal tissues,and its expression level was interpreted in terms of various clinical characteristics.Results: The expression of MIM mRNA in breast carcinoma was higher than that of adjacent tissues(P0.05) and it was associated with lymph node metastasis(P0.01),tumor size,and TNM stages(P0.05),but not age,histological grade,pathological type,ER,PR,CerbB-2 and Ki-67(P0.05).Conclusion: Overexpression of MIM mRNA may be a useful marker to predict metastasis of breast carcinoma.It may served as a biomarker for the prediction of moderate or advanced breast carcinoma,and may also prove to be a potential therapeutic target in breast carcinoma.
Key concepts: Breast carcinoma, Metastasis, Clinical significance, Biomarker, Carcinoma, Pathological, Medicine, Breast cancer